|
|
|
|
|
|
by rolph
1754 days ago
|
|
|
a) "In vitro studies have shown the efficacy of Ivermectin (IV) to inhibit the SARS—CoV-2 viral replication, but questions remained as to in-vivo applications" [0] b) "Sixty-three patients with positive PCR result were randomized into three arms of the study. There was 1 withdrawal, thus 62 patients completed the study" [0] c) "We cannot conclude in this study that Ivermectin has a place in prophylaxis, but this warrants investigation." [0] [0] https://academic.oup.com/qjmed/advance-article/doi/10.1093/q... |
|
|